InsiderFlow

Kamal Adawi

XGN

Kamal Adawi serves as officer: Chief Financial Officer at Exagen Inc. (XGN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$75.2K

Net Position

Net Seller

$75.2K

Companies Traded

2

FATE, XGN

Active Period

Feb 2023 – Nov 2026

5 total trades

Most Recent

Sell FATE

Nov 4, 2026 · $13.5K

Kamal Adawi's Insider Trading at Exagen Inc. (XGN)

Buys

0 · $0.00

Sells

4 · $61.6K

Total Shares Bought

0

Total Shares Sold

29,010

XGN Price Chart
Loading chart...
DateTypeValue
Mar 6, 2024 Sell$24.4K
Feb 8, 2024 Sell$13.1K
Mar 3, 2023 Sell$8.4K
Feb 10, 2023 Sell$15.7K

Kamal Adawi's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

0 · $0.00

Sells

1 · $13.5K

Total Shares Bought

0

Total Shares Sold

6,582

FATE Price Chart
Loading chart...
DateTypeValue
Nov 4, 2026 Sell$13.5K